Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Edición: | 1st ed. 2013. |
| Materias: |
Tabla de Contenidos:
- Endocannabinoids and monoamines: modulating the modulators
- Endocannabinoid-mediated synaptic plasticity
- Current cannabinoid receptor nomenclature and pharmacological principles
- Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction
- Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders
- Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers
- Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion
- Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function
- Endocannabinoids, Monoamines and Stress
- Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders
- Endocannabinoid Signaling and the Regulation of the Serotonin System
- Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors
- Involvement of serotonergic system in cannabinoid analgesia
- Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis.